Skip Navigation LinksHome»Products»Product Details
Product In-Details

XerovirinC ® Tablets

As a new contribution in the Gastroenterology Field, Minapharm presented Xerovirinc®, the broad-spectrum anti-infective that exhibits broad-spectrum activity against anaerobic bacteria and parasites.

Ingredient: Nitazoxanide 500mg
Multinational Partner: MINAPHARM
Launch Date: October 1, 2009
Pack: XerovirinC® is available in a box of three strips, each strip contains six tablets.

Product General

Disease Area

XerovirinC is indicated as a potent anti-diarrheal and against selected anaerobic bacteria as well as Rota Virus.

Insert leaflet
  • COMPOSITION:

Each film coated toblet contains 500mg Nitazoxanide.

 

  • INDICATIONS:

 Xerovirinc® is used in the treatment of:- Cryptosporidiosis in immunocompromised patients, including those with AIDS or HIV infection. - Helminthic infections.- Diarrhea caused by Giordio lamblia or Cryptosporidium parvum.

 

  • DOSE: 

Tablets: Patients of 12 years old or more: 1 tablet every 12 hours with food for 3 days.

Suspension: Age 1.3 years: 5 ml every 12 hours with food. Age 4-11years: 10 ml every 12 hours with food. Age 12 years or more: 25 ml every 12 hours with food. The treatment is For 3 days.

Scientific News Read More »

Latest Products Read More »

Newsletter Sign-up

Stay connected, subscribe to our newsletter for news and updates.

     

Office Address

Address: El-Bardissi St., 2T Takseem Asmaa Fahmy St., Heliopolis, Cairo - Egypt.
Phone: (+202) 2414-3170/1/2/3/4/5
Fax: (+202) 2414-3179

Social Media